Prostate Cancer clinical trials in Australia
67 prostate cancer trials recruiting in Australia
Prostate cancer is the most commonly diagnosed cancer in Australian men. Areas of active research include new hormonal therapies, PARP inhibitors, PSMA-targeted treatments, and immunotherapy for castration-resistant and hormone-sensitive prostate cancer.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your prostate cancer in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting prostate cancer trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Prostate Cancer clinical trials: common questions
The things people most often ask about prostate cancer trials.
Most prostate cancers grow in response to male hormones (androgens), so reducing testosterone is one of the foundations of prostate cancer treatment. Castration-resistant prostate cancer is the term used when the cancer continues to grow despite hormone therapy that has lowered testosterone to very low levels. It can still be limited to the prostate area or have spread elsewhere in the body, and it's the setting in which a large share of prostate cancer research takes place.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.